R-MVST Cells for Treatment of Viral Infections in Children and Young Adults

NCT06926894 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Epstein-Barr Virus
Cytomegalovirus Infections
Adenovirus
BK Virus Infection
Immune Deficiency

Interventions

DRUG: Rapidly generated virus specific T (R-MVST) cells

Sponsor

Columbia University